RELIEF THERAPEUTICS Holding SA and the World Orphan Drug Alliance announced an exclusive, long-term distribution agreement between Relief Therapeutics’ subsidiary APR Applied Pharma Research SA and WODA’s member company Vector Pharma FZCO to introduce PKU GOLIKE Plus®3-16 in the Middle East.
